{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T15:13:42Z","timestamp":1694790822656},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/aco.0b013e32835e820e","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T13:48:35Z","timestamp":1360072115000},"page":"164-170","source":"Crossref","is-referenced-by-count":5,"title":["Do corticosteroids improve outcome for any critical illness?"],"prefix":"10.1097","volume":"26","author":[{"given":"Baruch M.","family":"Batzofin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoram G.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane F.","family":"Ledot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210129","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.39.3.457","article-title":"The influence of the adrenal glands on resistance: II. The toxic effect of killed bacteria in adrenalectomized rats.","volume":"39","author":"Scott","year":"1924","journal-title":"J Exp Med"},{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis.","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/j.lpm.2011.04.023","article-title":"Pathophysiology of acute respiratory syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment.","volume":"40","author":"Meduri","year":"2011","journal-title":"Presse Med"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: concensus statement from an international task force by the American College of Critical Care Medicine.","volume":"36","author":"Marik","year":"2008","journal-title":"Crit Care Med"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","article-title":"Corticosteroid treatment in sepsis: a critical appraisal and meta-analysis of the literature.","volume":"24","author":"Cronin","year":"1995","journal-title":"Crit Care Med"},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"R7-11-20210129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone.","volume":"26","author":"Bollaert","year":"1998","journal-title":"Crit Care Med"},{"key":"R8-11-20210129","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","article-title":"Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.","volume":"27","author":"Briegel","year":"1999","journal-title":"Crit Care Med"},{"key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"A33","DOI":"10.1097\/00003246-199901001-00022","article-title":"Hydrocortisone reverses refractory septic shock.","volume":"27","author":"Chawla","year":"1999","journal-title":"Crit Care Med"},{"key":"R10-11-20210129","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1097\/01.CCM.0000186370.78639.23","article-title":"Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.","volume":"33","author":"Oppert","year":"2005","journal-title":"Crit Care Med"},{"key":"R11-11-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock.","volume":"34","author":"Dellinger","year":"2008","journal-title":"Intensive Care Med"},{"key":"R12-11-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"For the corticus study group. Hydrocortisone therapy for patients with septic shock.","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1086\/599343","article-title":"Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis.","volume":"49","author":"Sligl","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R14-11-20210129","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.2009.815","article-title":"Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.","volume":"301","author":"Annane","year":"2009","journal-title":"JAMA"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"COIITSS Study Investigators, Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"key":"R16-11-20210129","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","article-title":"Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.","volume":"37","author":"Russell","year":"2009","journal-title":"Crit Care Med"},{"key":"R17-11-20210129","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1503\/cmaj.090707","article-title":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial.","volume":"182","author":"Arabi","year":"2010","journal-title":"CMAJ"},{"key":"R18-11-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/CCM.0b013e31822d7938","article-title":"Corticosteroids after etomidate in critically ill patients: a randomized controlled tial.","volume":"40","author":"Payen","year":"2012","journal-title":"Crit Care Med"},{"key":"R19-11-20210129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone.","volume":"26","author":"Bollaert","year":"1998","journal-title":"Crit Care Med"},{"key":"R20-11-20210129","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1378\/chest.06-1976","article-title":"Epidemiology and outcomes of acute lung injury.","volume":"131","author":"Rubenfed","year":"2007","journal-title":"Chest"},{"key":"R21-11-20210129","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","article-title":"High-Dose corticosteroids in patients with the adult respiratory distress syndrome.","volume":"317","author":"Bernard","year":"1987","journal-title":"NEJM"},{"key":"R22-11-20210129","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone infusion in early severe ARDS.","volume":"131","author":"Meduri","year":"2007","journal-title":"Chest"},{"key":"R23-11-20210129","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/CCM.0b013e318232da5e","article-title":"Effects of methylprednisolone infusion of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome.","volume":"40","author":"Seam","year":"2012","journal-title":"Crit Care Med"},{"key":"R24-11-20210129","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1440-1843.2007.01060.x","article-title":"Do glucocorticoids decrease mortality in acute respiratory distress syndrome A meta-analysis.","volume":"12","author":"Agarwal","year":"2007","journal-title":"Respirology"},{"key":"R25-11-20210129","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/bmj.39537.939039.BE","article-title":"Corticosteroids in the prevention and treatment of acute respiratory distress sybdrome in adults: metaanalysis.","volume":"336","author":"Peter","year":"2008","journal-title":"BMJ"},{"key":"R26-11-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.280.2.159","article-title":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized control trial.","volume":"280","author":"Meduri","year":"1998","journal-title":"JAMA"},{"key":"R27-11-20210129","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.","volume":"354","author":"Steinberg","year":"2006","journal-title":"N Engl J Med"},{"key":"R28-11-20210129","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/CCM.0b013e31819fb507","article-title":"Use of corticosteroids in acute lung injury and acute respiratory distress sybdrome: a systematic review and meta-analysis.","volume":"37","author":"Tang","year":"2009","journal-title":"Crit Care Med"},{"key":"R29-11-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00134-007-0933-3","article-title":"Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature.","volume":"34","author":"Meduri","year":"2008","journal-title":"Intensive Care Med"},{"key":"R30-11-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jcrc.2009.08.009","article-title":"Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome and severe pneumonia: a metaanalysis of randomized controlled trials.","volume":"25","author":"Lamontagne","year":"2010","journal-title":"J Crit Care"},{"key":"R31-11-20210129","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/j.lpm.2011.04.023","article-title":"Pathology of acute repiratory distress syndrome. Glucocorticoid receptor of inflammation and response to prolonged glucocorticoid treatment.","volume":"40","author":"Meduri","year":"2011","journal-title":"Presse Med"},{"key":"R32-11-20210129","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccc.2011.05.007","article-title":"Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome.","volume":"27","author":"Marik","year":"2011","journal-title":"Crit Care Clin"},{"key":"R33-11-20210129","first-page":"1301","article-title":"The Acute Respiratory distress Syndrome Network.","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"R34-11-20210129","first-page":"2526","article-title":"ARDS Definition Task ForceAcute respiratory distress syndrome: the Berlin Definition.","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"R35-11-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1164\/rccm.200909-1420OC","article-title":"Lung pathology in fatal novel human influenza A (H1N1) infection.","volume":"181","author":"Mauad","year":"2010","journal-title":"Am J Resp Crit Care Med"},{"key":"R36-11-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00134-009-1727-6","article-title":"H1N1 influenza A virus-associated lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.","volume":"36","author":"Quispe-Laime","year":"2010","journal-title":"Intensive Care Med"},{"key":"R37-11-20210129","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.201101-0135OC","article-title":"Early corticosteroids in severe influenza AH1N1 pneumonia and acute respiratory distress syndrome.","volume":"183","author":"Brun-Buisson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R38-11-20210129","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00134-010-2078-z","article-title":"Use of corticosteroid therapy in patients affected by severe pandemic H1N1 v Influenza A infection.","volume":"37","author":"Martin-Loeches","year":"2011","journal-title":"Intensive Care Med"},{"key":"R39-11-20210129","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis an outcomes of patients with community-acquired pneumonia. A meta-analysis.","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"R40-11-20210129","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.02.00295102","article-title":"Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.","volume":"20","author":"Antunes","year":"2002","journal-title":"Eur Resp J"},{"key":"R41-11-20210129","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study.","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R42-11-20210129","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of stay in patients with community-acquired pneumonia: a randomised double-blind, placebo-controlled trial.","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet"},{"key":"R43-11-20210129","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc10103","article-title":"Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.","volume":"15","author":"Fernandez-Serrano","year":"2011","journal-title":"Crit Care"},{"key":"R44-11-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcrc.2010.07.014","article-title":"Impact of systemic corticosteroids on the clinical course and outcomes of patients wih severe community-acquired pneumonia: a cohort study.","volume":"26","author":"Salluh","year":"2011","journal-title":"J Crit Care"},{"key":"R45-11-20210129","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial.","volume":"181","author":"Snijders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R46-11-20210129","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11940-010-0086-5","article-title":"Meningococcal Meningitis.","volume":"12","author":"Branco","year":"2010","journal-title":"Curr Treatment Option Neurol"},{"key":"R48-11-20210129","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1474-4422(10)70023-5","article-title":"Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data.","volume":"9","author":"van der Beek","year":"2010","journal-title":"Lancet Neurol"},{"key":"R49-11-20210129","first-page":"229","article-title":"Adjunctive dexamethasone in meningitis: does value depend on clinical setting Lancet N","volume":"9","author":"McIntyre","year":"2010","journal-title":"eurol"},{"key":"R50-11-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/313910","article-title":"Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe and seasonal.","volume":"31","author":"Gordon","year":"2000","journal-title":"Clin Inf Dis"},{"key":"R51-11-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11940-011-0162-5","article-title":"Acute treatment options for spinal cord injury.","volume":"14","author":"Markandaya","year":"2012","journal-title":"Curr Treat Options Neurol"},{"key":"R52-11-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3171\/jns.1992.76.1.0023","article-title":"Methylprednisolone o naloxone treatment after acute spinal cord injury: 1 year follow-up data. Results of the second National Acute Spinal Cord Injury Study.","volume":"76","author":"Bracken","year":"1992","journal-title":"J Neurosurg"},{"key":"R53-11-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3171\/jns.1998.89.5.0699","article-title":"Methylprednisolone or tirikazad nesylate admistration after acute spinal cord injury: 1 year follow-up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.","volume":"89","author":"Bracken","year":"1998","journal-title":"J Neurosurg"},{"key":"R54-11-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.sc.3101681","article-title":"High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients.","volume":"43","author":"Qian","year":"2005","journal-title":"Spinal Cord"},{"key":"R55-11-20210129","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/BRS.0b013e31823a07a2","article-title":"Changes in the use of the methylprednisolone protocol for traumatic spinal cord injury in Switzerland.","volume":"37","author":"Felleiter","year":"2012","journal-title":"Spine"},{"key":"R56-11-20210129","first-page":"CD001046","article-title":"Steroids for acute spinal cord injury. Cochrane Database Syst Rev.","volume":"1","author":"Bracken","year":"18","journal-title":"2012 Jan"},{"key":"R57-11-20210129","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(04)17188-2","article-title":"Effect of intravenous coricosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomized placebo -controlled trial.","volume":"364","author":"Roberts","year":"2004","journal-title":"Lancet"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0b013e32835e820e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:55:30Z","timestamp":1620942930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-201304000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0b013e32835e820e","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}